REFRACTORY SEIZURES

Clinical trials for REFRACTORY SEIZURES explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY SEIZURES trials appear

Sign up with your email to follow new studies for REFRACTORY SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for controlling devastating seizures in rare genetic disorder

Disease control Ongoing

This study is testing whether adding the medication ZX008 (fenfluramine) to existing treatments can better control seizures in people with CDKL5 deficiency disorder, a rare genetic condition that causes severe epilepsy and developmental delays. The trial involves children and adu…

Matched conditions: REFRACTORY SEIZURES

Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control

Last updated Apr 02, 2026 10:12 UTC

REFRACTORY SEIZURES

Get alerted when new REFRACTORY SEIZURES trials appear

New hope for controlling devastating seizures in rare genetic disorder